Business Description
Tellgen Corp
ISIN : CNE100002P42
Share Class Description:
SZSE:300642: Class ACompare
Compare
Traded in other countries / regions
300642.China IPO Date
2017-04-21Description
Tellgen Corp manufactures and distributes in vitro diagnostic devices for detection of tumor. Its products include tumor marker, human papillomavirus, real time PCR, DNA methylation, autoimmune antibody, infectious disease and others. The company has developed products in the fields of tumor detection, cervical cancer screening, DNA methylation detection, male infertility and prenatal and postnatal care. Its products include tumor marker series products, human papillomavirus series products, Y chromosome microdeletion detection products, real time PCR, autoimmune antibody, and others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 33.54 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.2 | |||||
| Interest Coverage | 114.26 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 11.45 | |||||
| Beneish M-Score | -2.67 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.5 | |||||
| 3-Year EBITDA Growth Rate | -3.7 | |||||
| 3-Year EPS without NRI Growth Rate | -13.8 | |||||
| 3-Year FCF Growth Rate | 12.9 | |||||
| 3-Year Book Growth Rate | 6.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.83 | |||||
| 9-Day RSI | 36.43 | |||||
| 14-Day RSI | 40.97 | |||||
| 6-1 Month Momentum % | -30.32 | |||||
| 12-1 Month Momentum % | -38.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.12 | |||||
| Quick Ratio | 5.88 | |||||
| Cash Ratio | 3.81 | |||||
| Days Inventory | 365.2 | |||||
| Days Sales Outstanding | 168.06 | |||||
| Days Payable | 148.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.15 | |||||
| Dividend Payout Ratio | 0.4 | |||||
| 3-Year Dividend Growth Rate | -3.4 | |||||
| Forward Dividend Yield % | 1.15 | |||||
| 5-Year Yield-on-Cost % | 1.67 | |||||
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | 1.61 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.15 | |||||
| Operating Margin % | 13.74 | |||||
| Net Margin % | 14.35 | |||||
| FCF Margin % | 9.82 | |||||
| ROE % | 4.91 | |||||
| ROA % | 4.44 | |||||
| ROIC % | 6.49 | |||||
| ROC (Joel Greenblatt) % | 11.71 | |||||
| ROCE % | 4.67 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 28.8 | |||||
| PE Ratio without NRI | 25.83 | |||||
| Shiller PE Ratio | 16.65 | |||||
| Price-to-Owner-Earnings | 240.56 | |||||
| PS Ratio | 4.12 | |||||
| PB Ratio | 1.4 | |||||
| Price-to-Tangible-Book | 1.45 | |||||
| Price-to-Free-Cash-Flow | 42.2 | |||||
| Price-to-Operating-Cash-Flow | 13.44 | |||||
| EV-to-EBIT | 24.11 | |||||
| EV-to-EBITDA | 24.11 | |||||
| EV-to-Revenue | 3.34 | |||||
| EV-to-FCF | 36.56 | |||||
| Price-to-Projected-FCF | 1.29 | |||||
| Price-to-Graham-Number | 1.29 | |||||
| Price-to-Net-Current-Asset-Value | 2.89 | |||||
| Price-to-Net-Cash | 6.53 | |||||
| Earnings Yield (Greenblatt) % | 4.15 | |||||
| FCF Yield % | 2.37 | |||||
| Forward Rate of Return (Yacktman) % | -9.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tellgen Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 514.037 | ||
| EPS (TTM) (Â¥) | 0.451 | ||
| Beta | 1.25 | ||
| Volatility % | 28.81 | ||
| 14-Day RSI | 40.97 | ||
| 14-Day ATR (Â¥) | 0.632367 | ||
| 20-Day SMA (Â¥) | 14.038 | ||
| 12-1 Month Momentum % | -38.01 | ||
| 52-Week Range (Â¥) | 9.94 - 21.86 | ||
| Shares Outstanding (Mil) | 164.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tellgen Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tellgen Corp Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tellgen Corp Frequently Asked Questions
What is Tellgen Corp(SZSE:300642)'s stock price today?
The current price of SZSE:300642 is ¥12.99. The 52 week high of SZSE:300642 is ¥21.86 and 52 week low is ¥9.94.
When is next earnings date of Tellgen Corp(SZSE:300642)?
The next earnings date of Tellgen Corp(SZSE:300642) is .
Does Tellgen Corp(SZSE:300642) pay dividends? If so, how much?
The Dividend Yield %  of Tellgen Corp(SZSE:300642) is 1.15% (As of Today), Highest Dividend Payout Ratio of Tellgen Corp(SZSE:300642) was 0.51. The lowest was 0.14. And the median was 0.3. The  Forward Dividend Yield % of Tellgen Corp(SZSE:300642) is 1.15%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers